This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Analysts downgraded Qiagen, Alcoa and Dutch Bros, cutting price targets for Qiagen to $52 and Dutch Bros to $46.
Stocks · News reference
Elanco Announces Product Launches and Regulatory Approvals in Animal Health
Elanco has launched Befrena™ (tirnovetmab), a new anti-IL-31 monoclonal antibody for canine dermatology, and announced several regulatory updates including an improved label for Zenrelia™.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Elanco Animal Health Appoints Jamie Preston as Chief People Officer
Elanco Animal Health has named Jamie Preston as its new Executive Vice President and Chief People Officer, effective November 3, 2026.
This Chipotle Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Wall Street analysts downgraded Accenture, Braze, Chipotle, SmartFinancial and more, with several price-target cuts.